Search research articles
Contact Us
Filters
Showing results (311-320 of 328) with videos related to
Page
of 33
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
June 30, 2014
HDX reveals unique fragment ligands for the vitamin D receptor
Matthew W Carson, Jun Zhang, Michael J Chalmers, et al.
Journal of Psychosocial Oncology
|
June 20, 2020
Online couples mindfulness-based intervention for young breast cancer survivors and their partners: A randomized-control trial
Mollie A Price-Blackshear, Steven D Pratscher, Danielle L Oyler, et al.
Psychosomatic Medicine
|
December 4, 2002
Changing face of pain: evolution of pain research in psychosomatic medicine
Francis J Keefe, Mark A Lumley, Angela L H Buffington, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 6, 2021
Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations
Kristina Montemayor, Kevin J Psoter, Noah Lechtzin, et al.
Journal of Shoulder and Elbow Surgery
|
December 17, 2013
Biceps tenodesis is a viable option for salvage of failed SLAP repair
Brian C Werner, Hakan C Pehlivan, Joseph M Hart, et al.
CBE Life Sciences Education
|
October 17, 2024
A Multi-institutional Cluster Analysis to Identify Groups of Courses with Exemplary Opportunity Gaps for Undergraduate Students in the Biological Sciences
Kameryn Denaro, Marco Molinaro, Stefano Fiorini, et al.
Journal of Medicinal Chemistry
|
July 29, 2015
Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site
John G Luz, Matthew W Carson, Bradley Condon, et al.
Journal of Pharmaceutical Sciences
|
April 24, 2013
Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors
Daniele Ouellet, Kenneth F Grossmann, Giselle Limentani, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 8, 2013
Metabolism and disposition of oral dabrafenib in cancer patients: proposed participation of aryl nitrogen in carbon-carbon bond cleavage via decarboxylation following enzymatic oxidation
David A Bershas, Daniele Ouellet, Donna B Mamaril-Fishman, et al.
British Journal of Clinical Pharmacology
|
December 16, 2017
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours
Noelia Nebot, Hendrik-Tobias Arkenau, Jeffrey R Infante, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 328) with videos related to
Sort By:
Page
of 33
Bioorganic & Medicinal Chemistry Letters
|
June 30, 2014
HDX reveals unique fragment ligands for the vitamin D receptor
Matthew W Carson, Jun Zhang, Michael J Chalmers, et al.
Journal of Psychosocial Oncology
|
June 20, 2020
Online couples mindfulness-based intervention for young breast cancer survivors and their partners: A randomized-control trial
Mollie A Price-Blackshear, Steven D Pratscher, Danielle L Oyler, et al.
Psychosomatic Medicine
|
December 4, 2002
Changing face of pain: evolution of pain research in psychosomatic medicine
Francis J Keefe, Mark A Lumley, Angela L H Buffington, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 6, 2021
Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations
Kristina Montemayor, Kevin J Psoter, Noah Lechtzin, et al.
Journal of Shoulder and Elbow Surgery
|
December 17, 2013
Biceps tenodesis is a viable option for salvage of failed SLAP repair
Brian C Werner, Hakan C Pehlivan, Joseph M Hart, et al.
CBE Life Sciences Education
|
October 17, 2024
A Multi-institutional Cluster Analysis to Identify Groups of Courses with Exemplary Opportunity Gaps for Undergraduate Students in the Biological Sciences
Kameryn Denaro, Marco Molinaro, Stefano Fiorini, et al.
Journal of Medicinal Chemistry
|
July 29, 2015
Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site
John G Luz, Matthew W Carson, Bradley Condon, et al.
Journal of Pharmaceutical Sciences
|
April 24, 2013
Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors
Daniele Ouellet, Kenneth F Grossmann, Giselle Limentani, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 8, 2013
Metabolism and disposition of oral dabrafenib in cancer patients: proposed participation of aryl nitrogen in carbon-carbon bond cleavage via decarboxylation following enzymatic oxidation
David A Bershas, Daniele Ouellet, Donna B Mamaril-Fishman, et al.
British Journal of Clinical Pharmacology
|
December 16, 2017
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours
Noelia Nebot, Hendrik-Tobias Arkenau, Jeffrey R Infante, et al.
Page
of 33